McNamara S - Search Results

1

Significant microbiological effect of inhaled tobramycin in young children with cystic fibrosis.

Gibson RL, Emerson J, McNamara S, Burns JL, Rosenfeld M, Yunker A, Hamblett N, Accurso F, Dovey M, Hiatt P, Konstan MW, Moss R, Retsch-Bogart G, Wagener J, Waltz D, Wilmott R, Zeitlin PL, Ramsey B; Cystic Fibrosis Therapeutics Development Network Study Group. Gibson RL, et al. Among authors: mcnamara s. Am J Respir Crit Care Med. 2003 Mar 15;167(6):841-9. doi: 10.1164/rccm.200208-855OC. Epub 2002 Dec 12. Am J Respir Crit Care Med. 2003. PMID: 12480612 Clinical Trial.

2

A phase I study of aerosolized administration of tgAAVCF to cystic fibrosis subjects with mild lung disease.

Aitken ML, Moss RB, Waltz DA, Dovey ME, Tonelli MR, McNamara SC, Gibson RL, Ramsey BW, Carter BJ, Reynolds TC. Aitken ML, et al. Among authors: mcnamara sc. Hum Gene Ther. 2001 Oct 10;12(15):1907-16. doi: 10.1089/104303401753153956. Hum Gene Ther. 2001. PMID: 11589832 Clinical Trial.

3

Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis.

Emerson J, Rosenfeld M, McNamara S, Ramsey B, Gibson RL. Emerson J, et al. Among authors: mcnamara s. Pediatr Pulmonol. 2002 Aug;34(2):91-100. doi: 10.1002/ppul.10127. Pediatr Pulmonol. 2002. PMID: 12112774

4

Inflammatory and microbiologic markers in induced sputum after intravenous antibiotics in cystic fibrosis.

Ordoñez CL, Henig NR, Mayer-Hamblett N, Accurso FJ, Burns JL, Chmiel JF, Daines CL, Gibson RL, McNamara S, Retsch-Bogart GZ, Zeitlin PL, Aitken ML. Ordoñez CL, et al. Among authors: mcnamara s. Am J Respir Crit Care Med. 2003 Dec 15;168(12):1471-5. doi: 10.1164/rccm.200306-731OC. Epub 2003 Sep 11. Am J Respir Crit Care Med. 2003. PMID: 12969869 Clinical Trial.

5

Prevalence of neutralizing antibodies against adeno-associated virus (AAV) types 2, 5, and 6 in cystic fibrosis and normal populations: Implications for gene therapy using AAV vectors.

Halbert CL, Miller AD, McNamara S, Emerson J, Gibson RL, Ramsey B, Aitken ML. Halbert CL, et al. Among authors: mcnamara s. Hum Gene Ther. 2006 Apr;17(4):440-7. doi: 10.1089/hum.2006.17.440. Hum Gene Ther. 2006. PMID: 16610931 Free PMC article.

6

Microbiology, safety, and pharmacokinetics of aztreonam lysinate for inhalation in patients with cystic fibrosis.

Gibson RL, Retsch-Bogart GZ, Oermann C, Milla C, Pilewski J, Daines C, Ahrens R, Leon K, Cohen M, McNamara S, Callahan TL, Markus R, Burns JL. Gibson RL, et al. Among authors: mcnamara s. Pediatr Pulmonol. 2006 Jul;41(7):656-65. doi: 10.1002/ppul.20429. Pediatr Pulmonol. 2006. PMID: 16703579 Clinical Trial.

7

Selection for Staphylococcus aureus small-colony variants due to growth in the presence of Pseudomonas aeruginosa.

Hoffman LR, Déziel E, D'Argenio DA, Lépine F, Emerson J, McNamara S, Gibson RL, Ramsey BW, Miller SI. Hoffman LR, et al. Among authors: mcnamara s. Proc Natl Acad Sci U S A. 2006 Dec 26;103(52):19890-5. doi: 10.1073/pnas.0606756104. Epub 2006 Dec 15. Proc Natl Acad Sci U S A. 2006. PMID: 17172450 Free PMC article.

8

Duration of treatment effect after tobramycin solution for inhalation in young children with cystic fibrosis.

Gibson RL, Emerson J, Mayer-Hamblett N, Burns JL, McNamara S, Accurso FJ, Konstan MW, Chatfield BA, Retsch-Bogart G, Waltz DA, Acton J, Zeitlin P, Hiatt P, Moss R, Williams J, Ramsey BW. Gibson RL, et al. Among authors: mcnamara s. Pediatr Pulmonol. 2007 Jul;42(7):610-23. doi: 10.1002/ppul.20625. Pediatr Pulmonol. 2007. PMID: 17534969

9

Oral corticosteroid therapy in cystic fibrosis patients hospitalized for pulmonary exacerbation: a pilot study.

Dovey M, Aitken ML, Emerson J, McNamara S, Waltz DA, Gibson RL. Dovey M, et al. Among authors: mcnamara s. Chest. 2007 Oct;132(4):1212-8. doi: 10.1378/chest.07-0843. Epub 2007 Jul 23. Chest. 2007. PMID: 17646219 Clinical Trial.

10

Impact of Pseudomonas and Staphylococcus infection on inflammation and clinical status in young children with cystic fibrosis.

Sagel SD, Gibson RL, Emerson J, McNamara S, Burns JL, Wagener JS, Ramsey BW; Inhaled Tobramycin in Young Children Study Group; Cystic Fibrosis Foundation Therapeutics Development Network. Sagel SD, et al. Among authors: mcnamara s. J Pediatr. 2009 Feb;154(2):183-8. doi: 10.1016/j.jpeds.2008.08.001. Epub 2008 Sep 25. J Pediatr. 2009. PMID: 18822427 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

345 results

Search Page